Diputada argentina dice que los laboratorios frenan al cannabis medicinal
6 octubre, 2017
El aceite de semillas de cáñamo y sus beneficios para tu piel
6 octubre, 2017
Mostrar todo

Investigación operativa multi-centros sobre el uso de drogas y la reducción de daños entre personas que viven con el VIH/Sida en la región del Medio Oriente y el Norte de África

MENAHRA presenta una encuesta sobre el acceso a servicios de salud y reducción de daños, identificando barreras clave y avenidas para el mejoramiento. Más información, en inglés, está disponible abajo. 


In the Middle East and North Africa (MENA) region, the access to Harm Reduction (HR), Human Immunodeficiency Virus (HIV) treatment, care and support services remains limited among People Living with HIV/AIDS-(PLHIV)-People Who Use Drugs (PWUDs)/People Who Inject Drugs (PWIDs). To acquire a comprehensive understanding of the drug use and HR situation among PLHIV-WUDs/WIDs, a Multicentre Operational Research (OR) was conducted by the Middle East and North Africa Harm Reduction Association (MENAHRA) with support from the Global Fund. A.

Research Objectives: i) To explore the drug use context among PLHIV-WUDs/WIDs; ii) To measure the levels of knowledge about HIV/AIDS, harms of drug use, and HR and healthcare services; iii) To identify HR and healthcare services and service provision; iv) To define the reasons leading to stigma and discrimination; v) To identify barriers and facilitators hindering/facilitating access to HR, HIV treatment, care and support services; and vi) To provide recommendations for improved HR and healthcare services for PLHIV-WUDs/WIDs in the region

OR subjects included 230 participants: 149 PLHIV-PWUDs/PWIDs and 81 key informants (KIs) from Morocco, Tunisia, Lebanon, Egypt, Pakistan and Afghanistan. Data were collected by trained fieldwork teams through focus group discussions (FGDs), case studies and semi-structured interviews and analysed using a socioecological framework.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert



Fuente

Deja un comentario

Tu dirección de correo electrónico no será publicada. Los campos obligatorios están marcados con *